YK 11

YK-11 functions as a selective androgen receptor modulator (SARM), exhibiting high binding affinity to androgen receptors in muscle and bone tissue. Unlike traditional steroids, it demonstrates minimal androgenic effects in non-muscle tissues. Its primary mechanism involves suppressing myostatin, a protein responsible for inhibiting muscle growth. By reducing myostatin levels, YK 11 may allow for increased muscular development potential.

Furthermore, YK-11 is noted to increase follistatin production—a protein that directly binds and neutralizes myostatin. This dual action on the myostatin pathway sets it apart from other SARMs. It also influences muscle cell signalling pathways involved in protein synthesis and fat metabolism.

Athletes typically run YK-11 cycles during cutting phases to preserve lean muscle mass while reducing body fat. Users report investigating its potential for recomping—simultaneously building muscle and losing fat—although results vary considerably.

Research also focuses on the compound’s effects on strength gains, with some studies exploring its ability to increase power output and reduce recovery times between sets. YK-11 is not typically used as a primary bulking agent due to its potent nature; however, it may be included in cycles targeting overall body composition improvement.

Post Cycle Therapy (PCT) is strongly recommended following YK-11 use to mitigate potential hormonal imbalances. Due to its suppressive effects, careful monitoring of hormone levels is advised.

Advanced users typically administer 10-30 mg/week, divided into multiple doses. Intermediate athletes may start with a lower dosage of 5-10mg/week. Cycle lengths commonly range from 4 to 8 weeks.

A typical cycle structure involves an initial loading phase (optional) followed by consistent weekly dosing. Cycles exceeding 8 weeks are not frequently reported and carry increased risk of side effects. Careful monitoring of bloodwork is essential throughout the cycle, particularly assessing testosterone levels, estrogen, and liver enzymes.

Due to its potency, YK-11 should be used cautiously and with a thorough understanding of potential risks. Combining it with other SARMs or steroids requires extensive research and careful consideration.

Users report potential side effects including androgenic activity (acne, hair loss), estrogen-related issues (gynecomastia, water retention) and liver stress. Hepatotoxicity is a concern with YK-11; therefore, incorporating liver support supplements is frequently advised.

Suppression of natural testosterone production is significant, necessitating a comprehensive PCT protocol post cycle—including SERMs like Clomiphene Citrate or Nolvadex. Age 21+ is strongly recommended before considering YK-11 use due to its impact on hormonal balance and potential long-term health effects.

Regular bloodwork (baseline, mid-cycle, post-cycle) is crucial for monitoring liver function, hormone levels, and overall health. Individuals with pre-existing medical conditions should not use this compound.

Mechanism of action

YK-11 selectively binds to androgen receptors, primarily inhibiting myostatin expression via SMAD signaling pathways, leading to increased muscle mass potential and reduced protein breakdown.